Theravance Biopharma Current Ratio 2012-2019 | TBPH

Theravance Biopharma current ratio from 2012 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Theravance Biopharma Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-06-30 $0.43B $0.11B 3.87
2019-03-31 $0.47B $0.11B 4.12
2018-12-31 $0.53B $0.10B 5.41
2018-09-30 $0.33B $0.10B 3.26
2018-06-30 $0.39B $0.09B 4.14
2018-03-31 $0.45B $0.11B 4.25
2017-12-31 $0.38B $0.06B 6.06
2017-09-30 $0.37B $0.05B 7.53
2017-06-30 $0.39B $0.06B 6.74
2017-03-31 $0.42B $0.05B 8.61
2016-12-31 $0.53B $0.05B 10.73
2016-09-30 $0.27B $0.05B 6.04
2016-06-30 $0.30B $0.05B 6.79
2016-03-31 $0.24B $0.05B 5.15
2015-12-31 $0.24B $0.05B 4.80
2015-09-30 $0.24B $0.03B 8.69
2015-06-30 $0.26B $0.02B 10.63
2015-03-31 $0.28B $0.03B 9.55
2014-12-31 $0.28B $0.04B 6.68
2014-09-30 $0.31B $0.04B 8.56
2014-06-30 $0.38B $0.04B 9.54
2014-03-31 $0.02B $0.04B 0.41
2013-12-31 $0.01B $0.04B 0.38
2013-09-30 $0.00B 0.00
2013-06-30 $0.00B 0.00
2013-03-31 $0.00B 0.00
2012-12-31 $0.01B $0.02B 0.48
2011-12-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.974B $0.060B
Theravance Biopharma, Inc. is a biopharmaceutical company. It is focused on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including bacterial infections, central nervous system (CNS)/pain, respiratory disease, and gastrointestinal (GI) motility dysfunction. Theravance Biopharma, Inc. is based in George Town, Cayman Islands.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $60.454B 37.23
Takeda Pharmaceutical (TAK) Japan $53.771B 8.41
Astellas Pharma (ALPMY) Japan $29.086B 13.86
Merck (MKGAF) Germany $14.682B 20.03
Eisai (ESALY) Japan $14.552B 22.28
Grifols, S.A (GRFS) Spain $14.047B 17.92
UCB SA (UCBJF) Belgium $13.839B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.212B 19.69
Ionis Pharmaceuticals (IONS) United States $8.785B 18.95
Neurocrine Biosciences (NBIX) United States $8.326B 0.00
IPSEN SA ADR (IPSEY) France $7.776B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 0.00
Sage Therapeutics (SAGE) United States $7.197B 0.00
Catalent (CTLT) United States $7.070B 27.94
Jazz Pharmaceuticals (JAZZ) Ireland $6.661B 8.77
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.118B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $5.172B 18.59
United Therapeutics (UTHR) United States $3.563B 0.00
FibroGen (FGEN) United States $3.305B 82.67
Evotec AG (EVTCY) Germany $3.277B 44.87
Arrowhead Pharmaceuticals (ARWR) United States $3.127B 71.70
Taro Pharmaceutical Industries (TARO) Israel $2.863B 10.26
Nektar Therapeutics (NKTR) United States $2.782B 0.00
PTC Therapeutics (PTCT) United States $2.175B 0.00
Tilray (TLRY) Canada $2.017B 0.00
Xencor (XNCR) United States $1.925B 41.97
Portola Pharmaceuticals (PTLA) United States $1.835B 0.00
Zogenix (ZGNX) United States $1.835B 0.00
Corcept Therapeutics (CORT) United States $1.597B 21.95
USANA Health Sciences (USNA) United States $1.529B 15.33
Pacira Pharmaceuticals (PCRX) United States $1.524B 55.47
Heron Therapeutics (HRTX) United States $1.413B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.362B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.308B 0.00
Radius Health (RDUS) United States $1.155B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.147B 18.92
ArQule (ARQL) United States $1.017B 0.00
TherapeuticsMD (TXMD) United States $0.948B 0.00
Aerie Pharmaceuticals (AERI) United States $0.905B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.837B 0.00
Dova Pharmaceuticals (DOVA) United States $0.810B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.808B 3.60
Endo (ENDP) Ireland $0.761B 1.34
Organogenesis Holdings (ORGO) United States $0.719B 0.00
Concordia (CXRXF) Canada $0.633B 0.00
Karyopharm Therapeutics (KPTI) United States $0.626B 0.00
Flexion Therapeutics (FLXN) United States $0.526B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.510B 0.00
Akebia Therapeutics (AKBA) United States $0.493B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.458B 0.00
Siga Technologies (SIGA) United States $0.440B 1.03
Lannett Co Inc (LCI) United States $0.437B 4.60
Indivior (INVVY) United States $0.437B 1.58
ChemoCentryx (CCXI) United States $0.422B 0.00
Translate Bio (TBIO) United States $0.409B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.402B 0.00
Collegium Pharmaceutical (COLL) United States $0.394B 0.00
Innate Pharma SA (IPHYF) France $0.392B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.366B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.365B 16.61
ImmunoGen (IMGN) United States $0.346B 0.00
DURECT (DRRX) United States $0.346B 0.00
Rafael Holdings (RFL) United States $0.320B 0.00
Harpoon Therapeutics (HARP) United States $0.319B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.301B 0.00
Dermira (DERM) United States $0.289B 0.00
OptiNose (OPTN) United States $0.282B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.278B 0.00
Ardelyx (ARDX) United States $0.276B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.264B 0.00
Recro Pharma (REPH) United States $0.248B 0.00
Molecular Templates (MTEM) United States $0.247B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.231B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.209B 0.00
Xeris Pharmaceuticals (XERS) United States $0.208B 0.00
GlycoMimetics (GLYC) United States $0.193B 0.00
KalVista Pharmaceuticals (KALV) United States $0.191B 0.00
CV Sciences (CVSI) United States $0.185B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.174B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.173B 0.00
Nature's Sunshine Products (NATR) United States $0.171B 28.55
Taiwan Liposome (TLC) Taiwan $0.169B 0.00
CannTrust Holdings (CTST) Canada $0.147B 0.00
Ocular Therapeutix (OCUL) United States $0.144B 0.00
IMV INC (IMV) Canada $0.141B 0.00
Concert Pharmaceuticals (CNCE) United States $0.140B 0.00
Redhill Biopharma (RDHL) Israel $0.138B 0.00
Calithera Biosciences (CALA) United States $0.137B 0.00
Generex Biotechnology (GNBT) United States $0.131B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.131B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.125B 0.00
MEI Pharma (MEIP) United States $0.118B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.111B 0.00
Jounce Therapeutics (JNCE) United States $0.109B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.088B 33.71
Cardiome Pharma (CORV) Canada $0.086B 0.00
MediWound (MDWD) Israel $0.082B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.080B 0.00
Aquestive Therapeutics (AQST) United States $0.080B 0.00
Majesco Entertainment (PTE) United States $0.076B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.076B 0.00
Lipocine (LPCN) United States $0.071B 0.00
Otonomy (OTIC) United States $0.069B 0.00
AgeX Therapeutics (AGE) United States $0.068B 0.00
Genocea Biosciences (GNCA) United States $0.068B 0.00
Neos Therapeutics (NEOS) United States $0.068B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.068B 0.00
Champions Oncology (CSBR) United States $0.066B 0.00
RENEURON GP (RNUGF) United Kingdom $0.065B 0.00
Novan (NOVN) United States $0.064B 0.00
Natural Alternatives (NAII) United States $0.062B 9.35
IntelGenx Technologies (IGXT) Canada $0.061B 0.00
SCYNEXIS (SCYX) United States $0.058B 0.00
Aclaris Therapeutics (ACRS) United States $0.058B 0.00
ElectroCore (ECOR) United States $0.058B 0.00
Infinity Pharmaceuticals (INFI) United States $0.058B 0.00
Nivalis Therapeutics (ALPN) United States $0.056B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.055B 0.00
Pharmaxis (PXSLY) Australia $0.055B 0.00
Iterum Therapeutics (ITRM) Ireland $0.054B 0.00
Melinta Therapeutics (MLNT) United States $0.054B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.052B 0.00
Capnia (SLNO) United States $0.050B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
CTI BioPharma (CTIC) United States $0.044B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.043B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.038B 0.00
Mast Therapeutics (SVRA) United States $0.036B 0.00
India Globalization Capital (IGC) United States $0.034B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.032B 0.00
Jaguar Animal Health (JAGX) United States $0.032B 0.00
Bio-Path Holdings (BPTH) United States $0.031B 0.00
PharmAthene (ALT) United States $0.030B 0.00
Biomerica (BMRA) United States $0.030B 0.00
Opexa Therapeutics (ACER) United States $0.029B 0.00
China SXT Pharmaceuticals (SXTC) China $0.027B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
IsoRay (ISR) United States $0.021B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.016B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Vical (BBI) United States $0.013B 0.00
Regulus Therapeutics (RGLS) United States $0.013B 0.00
Heat Biologics (HTBX) United States $0.013B 0.00
Achieve Life Sciences (ACHV) United States $0.012B 0.00
Shineco (TYHT) China $0.012B 17.29
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
HANCOCK JAFFE (HJLI) United States $0.011B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.011B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
VAXART, INC (VXRT) United States $0.006B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
Onconova Therapeutics (ONTX) United States $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Hemispherx BioPharma (AIM) United States $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00